Interventions - Pharmacologic

Friday, May 11, 2018: 5:30 PM-7:00 PM
Hall Grote Zaal (de Doelen ICC Rotterdam)
5:30 PM
166.096
96 A Meta-Analysis of the Efficacy of Immediate Release Methylphenidate to Reduce Hyperactivity in Children with Autistic Spectrum Disorder
A. Bratt B. Masanyero-Bennie S. P. Kelley
5:30 PM
166.097
97 A Randomized, Double-Blind, Placebo Controlled Trial of 4 Weeks Intervention with Lactobacillus Plantarum PS128 in Autism Spectrum Disorder Boys in Taiwan
Y. W. Liu H. Y. Huang W. S. Peng Y. Y. Wu Y. C. Tsai
5:30 PM
166.098
98 Cannabidiol Based Medical Cannabis in Children with Autism- a Retrospective Feasibility Study
A. Aran H. Cassuto A. Lubotzky
5:30 PM
166.099
99 Effect of a Combination of Carnitine, Coenzyme Q10 and Alpha-Lipoic Acid (MitoCocktail) on Mitochondrial Function and Neurobehavioral Performance in Children with Autism Spectrum Disorder
A. Legido M. J. Goldenthal B. Garvin S. Damle K. Corrigan J. Connell D. Thao I. Valencia J. Melvin D. Khurana M. Grant C. J. Newschaffer
5:30 PM
166.100
100 Effect of Vitamin A Supplementation on Gut Microbiota in Children with Autism Spectrum Disorders - a Pilot Study
J. Liu X. Liu Q. X. Xiong T. Yang T. Cui L. N. Hou X. Lai S. Liu M. Guo H. X. Liang Q. Cheng J. Chen T. Li
5:30 PM
166.101
101 Management of Children and Youth with Neurodevelopmental Disorders (NDDs) in Community Settings Prior to Referral to a Tertiary Psychopharmacology Clinic
I. Kara M. Penner
5:30 PM
166.102
102 Medical Cannabinoids for Patients with Autistic Spectrum Disorder: Parents Perspective
O. E. Stolar D. Barchel T. De-Haan T. Ziv-Baran N. Saban G. Koren M. Berkovitch
5:30 PM
166.103
103 Mental Health Issues in Children and Youth with Autism Spectrum Disorder: Medication Use, Side Effects, and Monitoring
C. A. McMorris J. K. Lake B. L. Ncube R. Balogh T. Williamson
5:30 PM
166.104
104 Multisite Randomised Controlled Trial of Fluoxetine Versus Placebo for the Treatment of Restricted Repetitive and Stereotyped Behaviours in Children and Adolescents with Autism
C. Marraffa D. S. Reddihough M. O'Sullivan F. Orsini K. Lee A. Mouti P. Hazell M. Kohn D. R. Dossetor N. Silove J. Granich A. J. Whitehouse J. Wray P. J. Santosh
5:30 PM
166.105
105 One-Year Retention Effects of Multiple-Dose Oxytocin Treatment on Repetitive and Restricted Behaviors, Social Responsiveness and Attachment: A Randomized, Placebo-Controlled Trial
S. Bernaerts C. Dillen J. Steyaert K. Alaerts
5:30 PM
166.106
106 Oxytocin Administration during Delivery and the Autism Spectrum Disorder
T. Brahim N. Gaddour S. Missaoui L. Gaha
5:30 PM
166.107
107 Vitamin A Improves the Symptoms of Autism Spectrum Disorders and Decreases 5-Hydroxytryptamine (5-HT): A Pilot Study
M. Guo J. Zhu T. Yang X. Lai X. Liu J. Liu J. Chen T. Li
See more of: Interventions - Pharmacologic
<< Previous Panel | Next Panel >>